
WuXi Biologics completes first GMP production at new MFG17 facility with strong process performance.
WuXi Biologics has successfully completed the first GMP production campaign at its new MFG17 drug substance facility in Shanghai, demonstrating stable process parameters and expected yields. The facility, with a 9,000-liter capacity and flexible sing...


